Kisspeptin Does More Than Control Reproduction — It Shapes Sexual Desire and Mood | Research

The takeaway

Kisspeptin enhances brain responses to sexual stimuli, reduces negative mood, and modulates attraction processing — expanding its role from reproductive hormone control to sexual and emotional brain function.

Beyond hormones
fMRI studies show kisspeptin doesn't just control reproductive hormones — it directly modulates brain responses to sexual stimuli, attraction cues, and mood

What the researchers found

Review consolidating evidence that kisspeptin enhances limbic brain activity to sexual stimuli, reduces negative mood, and modulates brain responses to attraction cues, expanding its role beyond reproductive axis regulation.

Why it matters

Establishes kisspeptin as a potential therapeutic target for psychosexual disorders, bridging reproductive endocrinology and emotional/sexual brain processing.

How the study worked

Narrative review of preclinical and clinical kisspeptin research.

What this study cannot tell us

Review article. Most human data from a single research group.

How to read the evidence

This is a narrative review from a leading kisspeptin research group, synthesizing preclinical and clinical fMRI data. The 'Moderate' grade reflects the review format and the relatively early stage of human brain imaging studies on kisspeptin.

When this study was published

Published in 2017, this review captured the emerging evidence for kisspeptin's brain effects beyond reproduction. Since then, additional clinical studies have further supported these findings, including larger fMRI trials and exploratory therapeutic applications.

The bigger picture

The discovery that kisspeptin acts beyond the hypothalamus — in limbic and paralimbic brain regions associated with emotion, motivation, and reward — reframes it from a purely reproductive peptide into a broader neuromodulator of sexual behavior and emotional state. This has major implications for treating conditions like hypoactive sexual desire disorder (HSDD), where the disconnect between reproductive hormones and sexual motivation is the core problem. Kisspeptin could potentially address both simultaneously.

Questions still open

Could kisspeptin-based therapies treat hypoactive sexual desire disorder more effectively than current options?
Does kisspeptin's mood-improving effect persist with repeated administration, or is it only acute?
Are kisspeptin's sexual and emotional brain effects the same in men and women?

Common questions

How can a reproductive hormone affect sexual desire and mood?

Kisspeptin receptors aren't just in the hypothalamus (which controls reproductive hormones) — they're also in limbic and paralimbic brain regions that process emotions, motivation, reward, and sexual arousal. When kisspeptin activates these brain areas, it enhances responses to sexual cues and improves mood. This makes biological sense: reproduction requires both the hormonal machinery AND the motivation and desire to engage in sexual behavior.

Could kisspeptin treat low sexual desire?

That's the therapeutic implication of this research. Conditions like hypoactive sexual desire disorder (HSDD) involve a disconnect between normal reproductive hormones and reduced sexual motivation. Because kisspeptin bridges both systems — controlling hormones AND modulating the brain's sexual/emotional processing — it could potentially address the root cause in ways that current treatments cannot. Clinical trials exploring this application are underway.

Read the original research

Emerging Roles of Kisspeptin in Sexual and Emotional Brain Processing.

Neuroendocrinology, 106(2), 195-202

View on PubMed ↗Publisher’s paper ↗

Citation

Comninos, Alexander N; Dhillo, Waljit S. (2017). Emerging Roles of Kisspeptin in Sexual and Emotional Brain Processing.. Neuroendocrinology, 106(2), 195-202. https://doi.org/10.1159/000479326